Calendario›BIAF›Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients Using the CyPath Lung Assay
Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients Using the CyPath Lung Assay
Ensayo de bioAffinity Technologies, Inc. en Cancer de pulmon.
Más ensayos de: Cáncer de pulmón.
- Fase
- no aplica
- Estado
- Sin noticias del promotor
- Participantes
- 40
- Centros
- 1
- Fin del objetivo primario
- mar 2024
previstos
estimado por el promotor
Qué significa cada fase y cada estado.
Estudio observacional. Comenzó en ago 2023.
Qué mide
Objetivo principal (12 meses)
Cómo lo describe el promotor
En el documentoEn inglés, del registroThere are numerous Department of Defense (DoD) beneficiaries enrolled in the various lung cancer screening programs across the DoD. This study may enable patients to forego annual CT lung cancer screening or help to predict cancerous nodules without interventional procedures. This is a prospective observational study of sputum cytology using flow cytometry to analyze sputum samples collected from patients in the active military who are undergoing annual lung cancer screening. The primary objective of this study is to analyze the cellular profiles of sputum samples collected from the Acapella® airway assist device in patients at higher risk for lung cancer. The target population are high risk patients for developing lung cancer, age 50-80 with a significant smoking history.
Más ensayos de BIAF
| Ensayo | Fase | Estado | Lectura de resultados |
|---|---|---|---|
| Collection of Sputum and Labeling for Lung Cancer | no aplica | Reclutando pacientes | dic 2025 (prevista, ya pasada: sin actualizar en el registro) |
| BA-004 | Sin fase asignada | Reclutando pacientes | abr 2029 (prevista) |
| Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung Cancer | no aplica | Completado | ago 2018 (real) |
| CyPath® | Sin fase asignada | Completado | abr 2015 (real) |
Todos los de BIAF, en su ficha.
Ficha completa en ClinicalTrials.gov (NCT05870592), actualizada en jul 2023.